517 related articles for article (PubMed ID: 18477341)
1. Use of physician education and computer alert to improve targeted use of gastroprotection among NSAID users.
Coté GA; Rice JP; Bulsiewicz W; Norvell JP; Christensen K; Bobb A; Postelnick M; Howden CW
Am J Gastroenterol; 2008 May; 103(5):1097-103. PubMed ID: 18477341
[TBL] [Abstract][Full Text] [Related]
2. Use of gastroprotection in patients discharged from hospital on nonsteroidal anti-inflammatory drugs.
Coté GA; Norvell JP; Rice JP; Bulsiewicz WJ; Howden CW
Am J Ther; 2008; 15(5):444-9. PubMed ID: 18806520
[TBL] [Abstract][Full Text] [Related]
3. Improving on our goal to reduce NSAID-induced GI complications: a challenging task?
Lanas A
Am J Gastroenterol; 2008 May; 103(5):1104-5. PubMed ID: 18477342
[TBL] [Abstract][Full Text] [Related]
4. Underutilization of preventive strategies in patients receiving NSAIDs.
Sturkenboom MC; Burke TA; Dieleman JP; Tangelder MJ; Lee F; Goldstein JL
Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii23-31. PubMed ID: 14585915
[TBL] [Abstract][Full Text] [Related]
5. The relative efficacies of gastroprotective strategies in chronic users of nonsteroidal anti-inflammatory drugs.
Targownik LE; Metge CJ; Leung S; Chateau DG
Gastroenterology; 2008 Apr; 134(4):937-44. PubMed ID: 18294634
[TBL] [Abstract][Full Text] [Related]
6. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
Goldstein JL; Huang B; Amer F; Christopoulos NG
Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
[TBL] [Abstract][Full Text] [Related]
7. Complications of nonsteroidal antiiflammatory drug gastropathy and use of gastric cytoprotection: experience at a tertiary care health center.
Bakowsky VS; Hanly JG
J Rheumatol; 1999 Jul; 26(7):1557-63. PubMed ID: 10405945
[TBL] [Abstract][Full Text] [Related]
8. Proton pump inhibitor co-therapy with nonsteroidal anti-inflammatory drugs--nice or necessary?
Laine L
Rev Gastroenterol Disord; 2004; 4 Suppl 4():S33-41. PubMed ID: 15580145
[TBL] [Abstract][Full Text] [Related]
9. Proton-pump inhibitors are associated with a reduced risk for bleeding and perforated gastroduodenal ulcers attributable to non-steroidal anti-inflammatory drugs: a nested case-control study.
Vonkeman HE; Fernandes RW; van der Palen J; van Roon EN; van de Laar MA
Arthritis Res Ther; 2007; 9(3):R52. PubMed ID: 17521422
[TBL] [Abstract][Full Text] [Related]
10. Strategies to optimize treatment with NSAIDs in patients at risk for gastrointestinal and cardiovascular adverse events.
Scheiman JM; Hindley CE
Clin Ther; 2010 Apr; 32(4):667-77. PubMed ID: 20435236
[TBL] [Abstract][Full Text] [Related]
11. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
[TBL] [Abstract][Full Text] [Related]
12. NSAID-related upper gastrointestinal bleeding: are risk factors considered during prophylaxis?
Dincer D; Duman A; Dikici H; Arici C; Suleymanlar I; Isitan F
Int J Clin Pract; 2006 May; 60(5):546-8. PubMed ID: 16700851
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of differences between indication and prescription of gastroprotection in patients with risk factors treated with nonsteroidal anti-inflammatory agents: the GAP study].
Lanas A; Muñoz M; Caballero Correa M; Martínez Jiménez P;
Gastroenterol Hepatol; 2010 Feb; 33(2):80-91. PubMed ID: 19931944
[TBL] [Abstract][Full Text] [Related]
14. Resident physician's knowledge of risk factors for upper gastrointestinal complications from NSAIDs.
Coté GA; Siqueira F; Rice JP; Howden CW
Am J Ther; 2009; 16(5):404-11. PubMed ID: 19955858
[TBL] [Abstract][Full Text] [Related]
15. The prevalence of risk factors for gastrointestinal complications and use of gastroprotection among persons hospitalized for cardiovascular disease.
Targownik LE; Al-Mamfud A
Aliment Pharmacol Ther; 2006 Mar; 23(6):743-9. PubMed ID: 16556176
[TBL] [Abstract][Full Text] [Related]
16. Hospitalizations for upper and lower GI events associated with traditional NSAIDs and acetaminophen among the elderly in Quebec, Canada.
Rahme E; Barkun A; Nedjar H; Gaugris S; Watson D
Am J Gastroenterol; 2008 Apr; 103(4):872-82. PubMed ID: 18371130
[TBL] [Abstract][Full Text] [Related]
17. Nonsteroidal anti-inflammatory drugs (NSAIDs), cyxlooxygenase-2 selective inhibitors (coxibs) and gastrointestinal harm: review of clinical trials and clinical practice.
Moore RA; Derry S; Phillips CJ; McQuay HJ
BMC Musculoskelet Disord; 2006 Oct; 7():79. PubMed ID: 17054784
[TBL] [Abstract][Full Text] [Related]
18. Primary care physician perceptions of non-steroidal anti-inflammatory drug and aspirin-associated toxicity: results of a national survey.
Chey WD; Eswaren S; Howden CW; Inadomi JM; Fendrick AM; Scheiman JM
Aliment Pharmacol Ther; 2006 Mar; 23(5):655-68. PubMed ID: 16480405
[TBL] [Abstract][Full Text] [Related]
19. Impact of adherence to concomitant gastroprotective therapy on nonsteroidal-related gastroduodenal ulcer complications.
Goldstein JL; Howard KB; Walton SM; McLaughlin TP; Kruzikas DT
Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1337-45. PubMed ID: 17088110
[TBL] [Abstract][Full Text] [Related]
20. COX-2 inhibitors: complex association with lower risk of hospitalization for gastrointestinal events compared to traditional NSAIDs plus proton pump inhibitors.
van der Linden MW; Gaugris S; Kuipers EJ; van Herk-Sukel MP; van den Bemt BJ; Sen SS; Herings RM
Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):880-90. PubMed ID: 19593747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
